CAPLIN POINT LABORATORIES LIMITED

Sector revisions Caplin Point Laboratories Limited NSE India S.E.

Stocks

CAPLIPOINT

INE475E01026

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:07 11/08/2026 pm IST			5-day change	1st Jan Change
2,629.60 ^INR	+0.22%		+2.24%	+43.06%

15/05	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
15/05	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	SUN PHARMACEUTICAL INDUSTRIES LTD.							33
	OTSUKA HOLDINGS CO., LTD.							12
	CIPLA LIMITED							36
	ZYDUS LIFESCIENCES LIMITED							30
	KRKA, D. D.							6
	GEDEON RICHTER							7
	ONO PHARMACEUTICAL CO., LTD.							12
	GLENMARK PHARMACEUTICALS LIMITED							11
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.						-	-
	AJANTA PHARMA LIMITED							14
	ASPEN PHARMACARE HOLDINGS LIMITED							4
	SIMCERE PHARMACEUTICAL GROUP LIMITED							4
	ASTRA INDUSTRIAL GROUP COMPANY						-	1
	HAW PAR CORPORATION LIMITED				-	-	-	1
	SUNSHINE LAKE PHARMA CO., LTD.		-		-		-	-
	JAMJOOM PHARMACEUTICALS FACTORY COMPANY							3
	APICHOPE PHARMACEUTICAL GROUP CO., LTD.						-	-
	Average							12
	Weighted average by Cap.							20

Generic Pharmaceuticals

Stock Market
Stocks
CAPLIPOINT Stock
CAPLIPOINT Stock
Sector Caplin Point Laboratories Limited
Sector revisions

As early as today, start finding the best investment opportunities!